Published in Gene Therapy Weekly, May 31st, 2007
The chemistry deployed for RNA cleavage and deprotection is more complex and hazardous than that used for DNA manufacture. Avecia has installed new large scale cleavage deprotection vessels and equipment to enable large scale siRNA manufacture in batch sizes of 75-100mmol.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.